Research graph
References from Diagnosis of ankylosing spondylitis. Local targets link to admitted publications; unresolved targets remain external evidence.
Axial spondyloarthritis.
10.1136/annrheumdis-2021-221035 · 2021 · External reference
The development of Assessment of SpondyloArthritis International Society classification criteria for axial spondyloarthritis (part II): validation and final selection.
10.1136/ard.2009.108233 · 2009 · External reference
Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci.
10.1038/ng.2667 · 2013 · External reference
Exploring the pathogenesis of spondylarthritis beyond HLA-B27: a descriptive review.
10.3390/ijms25116081 · 2024 · External reference
Pathophysiology and immunological basis of axial spondyloarthritis.
10.1016/j.berh.2023.101897 · 2023 · External reference
Recent updates in the immunopathology of type 3 immunity-mediated enthesitis.
10.1007/s11926-021-00995-y · 2021 · External reference
Why inhibition of IL-23 lacked efficacy in ankylosing spondylitis.
10.3389/fimmu.2021.614255 · 2021 · External reference
Evidence in support of the bone marrow as the primary lesion in axial spondyloarthritis.
10.1097/bor.0000000000000945 · 2023 · External reference
Performance of the ASAS classification criteria for axial and peripheral spondyloarthritis: a systematic literature review and meta-analysis.
10.1136/annrheumdis-2016-210747 · 2017 · External reference
Clinical, economic, and humanistic burden associated with delayed diagnosis of axial spondyloarthritis: a systematic review.
10.1007/s40744-020-00194-8 · 2020 · External reference
Global trends and research status in ankylosing spondylitis clinical trials: a bibliometric analysis of the last 20 years.
10.3389/fimmu.2023.1328439 · 2023 · External reference
Mesenchymal stem cells in heterotopic ossification in ankylosing spondylitis: a bibliometric study based on CiteSpace and VOSViewer.
10.2147/jir.s421962 · 2023 · External reference
bibliometrix: an R-tool for comprehensive science mapping analysis.
10.1016/j.joi.2017.08.007 · 2017 · External reference
Effects of print publication lag in dual format journals on scientometric indicators.
10.1371/journal.pone.0059877 · 2013 · External reference
Spectrum of spondyloarthritis among Chinese populations.
10.1007/s11926-022-01079-1 · 2022 · External reference
Global prevalence of spondyloarthritis: a systematic review and meta-regression analysis.
10.1002/acr.22831 · 2016 · External reference
The epidemiology of back pain, axial spondyloarthritis and HLA-B27 in the United States.
10.1097/maj.0b013e318294457f · 2013 · External reference
Diagnostic evaluation of the sacroiliac joints for axial spondyloarthritis: should MRI replace radiography?
10.1136/ard-2022-222986 · 2022 · External reference
Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group.
10.1136/ard.2009.110767 · 2009 · External reference
Descriptions of spinal MRI lesions and definition of a positive MRI of the spine in axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI study group.
10.1136/ard.2011.150680 · 2012 · External reference
Predictive values of inflammatory back pain, positive HLA B27 antigen and acute and chronic magnetic resonance changes in early diagnosis of spondyloarthritis. A study of 133 patients.
10.1371/journal.pone.0244184 · 2020 · External reference
A comprehensive assessment of hip damage in ankylosing spondylitis, especially early features.
10.3389/fimmu.2021.668969 · 2021 · External reference
Challenges in the diagnosis of axial spondyloarthritis.
10.1016/j.berh.2023.101871 · 2023 · External reference
Diagnostic accuracy in axial spondyloarthritis: a systematic evaluation of the role of clinical information in the interpretation of sacroiliac joint imaging.
10.1136/rmdopen-2023-004044 · 2024 · External reference
Can rheumatologists unequivocally diagnose axial spondyloarthritis in patients with chronic back pain of less than 2 years duration? Primary outcome of the 2-year SPondyloArthritis Caught Early (SPACE) cohort.
10.1136/ard-2023-224959 · 2024 · External reference
No evidence of a genetic causal relationship between ankylosing spondylitis and gut microbiota: a two-sample Mendelian randomization study.
10.3390/nu15041057 · 2023 · External reference
10.1371/journal.pone.0306792 · 2024 · Admitted local publication
Association between type 1 diabetes mellitus and ankylosing spondylitis: a two-sample Mendelian randomization study.
10.3389/fimmu.2023.1289104 · 2023 · External reference
Ankylosing spondylitis: acute/subacute vs. chronic iridocyclitis - a bidirectional two-sample Mendelian randomization study.
10.3389/fimmu.2023.1295118 · 2023 · External reference
Anti-CD74 IgA antibodies show diagnostic potential for axial spondyloarthritis but are not associated with microscopic gut inflammation.
10.1093/rheumatology/keac384 · 2023 · External reference
Diagnostic value of the anti-CD74 antibodies for axial spondyloarthritis: results of a prospective study in patients with suspicious low back pain.
10.1016/j.jbspin.2023.105533 · 2023 · External reference
Diagnostic value of anti-Kaiso autoantibody in axial spondyloarthritis.
10.3389/fimmu.2023.1156350 · 2023 · External reference
Serum metabolomics signatures associated with ankylosing spondylitis and TNF inhibitor therapy.
10.3389/fimmu.2021.630791 · 2021 · External reference
Prefoldin 5 and anti-prefoldin 5 antibodies as biomarkers for uveitis in ankylosing spondylitis.
10.3389/fimmu.2019.00384 · 2019 · External reference
Bioinformatics analysis of immune cell infiltration and diagnostic biomarkers between ankylosing spondylitis and inflammatory bowel disease.
10.1155/2023/9065561 · 2023 · External reference
Exploration of the shared pathways and common biomarker PAN3 in ankylosing spondylitis and ulcerative colitis using integrated bioinformatics analysis.
10.3389/fimmu.2023.1089622 · 2023 · External reference
Biomarker development for axial spondyloarthritis.
10.1038/s41584-020-0450-0 · 2020 · External reference
Goodbye to the term ‘ankylosing spondylitis’, hello ‘axial spondyloarthritis’: time to embrace the ASAS-defined nomenclature.
10.1136/ard-2023-225185 · 2024 · External reference
Ankylosing spondylitis: an autoimmune or autoinflammatory disease?
10.1038/s41584-021-00625-y · 2021 · External reference
Consensus-driven definition for unequivocal sacroiliitis on radiographs in juvenile spondyloarthritis.
10.3899/jrheum.2022-0890 · 2023 · External reference
Data-driven magnetic resonance imaging definitions for active and structural sacroiliac joint lesions in juvenile spondyloarthritis typical of axial disease: a cross-sectional international study.
10.1002/acr.25014 · 2023 · External reference
Comparison of patients with axial PsA and patients with axSpA and concomitant psoriasis: an analysis of the German register RABBIT-SpA.
10.1136/rmdopen-2022-002837 · 2023 · External reference
Influence of environmental factors on disease activity in spondyloarthritis: a prospective cohort study.
10.3899/jrheum.121081 · 2013 · External reference
Abrupt and unexpected stressful life events are followed with increased disease activity in spondyloarthritis: a two years web-based cohort study.
10.1016/j.jbspin.2018.05.009 · 2019 · External reference
Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial.
10.1016/s0140-6736(18)31946-9 · 2018 · External reference
